Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hahn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Materials (Basel, Switzerland)|May 27, 2023
3D Textiles Based on Warp Knitted Fabrics: A ReviewLars Hahn, Konrad Zierold, Anke Golla, et al.
Plos Computational Biology|October 21, 2016
rasbhari: Optimizing Spaced Seeds for Database Searching, Read Mapping and Alignment-Free Sequence ComparisonLars Hahn, Chris-André Leimeister, Rachid Ounit, et al.
Materials (Basel, Switzerland)|March 29, 2023
Improved Tensile and Bond Properties through Novel Rod Constructions Based on the Braiding Technique for Non-Metallic Concrete ReinforcementsAnwar Abdkader, Paul Penzel, Danny Friese, et al.
Materials (Basel, Switzerland)|April 13, 2023
Simulation of Tetrahedral Profiled Carbon Rovings for Concrete ReinforcementsPaul Penzel, Tobias Georg Lang, Philipp Benjamin Weigel, et al.
Materials (Basel, Switzerland)|August 26, 2022
Bond Modification of Carbon Rovings through ProfilingPaul Penzel, Maximilian May, Lars Hahn, et al.
BMC Cancer|February 26, 2020
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center studyC Benedikt Westphalen, Tobias Kukiolka, Benjamin Garlipp, et al.
The Lancet. Oncology|December 15, 2015
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trialMathias Rummel, Ulrich Kaiser, Christina Balser, et al.
International Journal of Cancer|October 10, 2020
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registrySalah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Materials (Basel, Switzerland)|May 27, 2023
3D Textiles Based on Warp Knitted Fabrics: A ReviewLars Hahn, Konrad Zierold, Anke Golla, et al.
Plos Computational Biology|October 21, 2016
rasbhari: Optimizing Spaced Seeds for Database Searching, Read Mapping and Alignment-Free Sequence ComparisonLars Hahn, Chris-André Leimeister, Rachid Ounit, et al.
Materials (Basel, Switzerland)|March 29, 2023
Improved Tensile and Bond Properties through Novel Rod Constructions Based on the Braiding Technique for Non-Metallic Concrete ReinforcementsAnwar Abdkader, Paul Penzel, Danny Friese, et al.
Materials (Basel, Switzerland)|April 13, 2023
Simulation of Tetrahedral Profiled Carbon Rovings for Concrete ReinforcementsPaul Penzel, Tobias Georg Lang, Philipp Benjamin Weigel, et al.
Materials (Basel, Switzerland)|August 26, 2022
Bond Modification of Carbon Rovings through ProfilingPaul Penzel, Maximilian May, Lars Hahn, et al.
BMC Cancer|February 26, 2020
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center studyC Benedikt Westphalen, Tobias Kukiolka, Benjamin Garlipp, et al.
The Lancet. Oncology|December 15, 2015
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trialMathias Rummel, Ulrich Kaiser, Christina Balser, et al.
International Journal of Cancer|October 10, 2020
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registrySalah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, et al.
Pageof 1